Emma Young is an award-winning science and health journalist and the author of Sane: How I shaped up my mind, improved my mental strength, and found calm. A former reporter and editor for New Scientist, working in London and Sydney, she now freelances from an attic in Sheffield. As E L Young (in the UK, Emma in the USA), she is also the author of the STORM series of science-based thrillers for kids.
Emma Young
From this contributor
For people with alexithymia, emotions are a mystery
One in 10 people struggle to recognize their emotions. New research suggests a vital link between our ability to sense our physical bodies and knowing how we feel.
For people with alexithymia, emotions are a mystery
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.